Being reliant on the pharmaceutical imports to encourage the free market competition, Qatar offers good market opportunities for medicinal products and medical devices manufacturers. To enter the region, manufacturers must obtain authorizations from the Ministry of Public Health, Pharmacy and Drug Control Department. However, entering the region challenges the manufacturers with complex Regulatory regime of Qatar.

Freyr with an updated knowledge over the region helps manufacturers navigate the Regulatory complexities for a successful compliance. Freyr’s Regulatory affairs consulting services for Qatar span across:

  • Medical Devices
  • Pharmaceuticals

Freyr Offerings

  • Strategic Regulatory Consulting
  • Regulatory roadmap for market access
  • Regulatory Affairs & Regulatory intelligence
  • Registration pathways and license management services
  • Pre-submissions Strategies
  • Regulatory Submissions (CTD)
  • Pharmacovigilance

Freyr Advantages

  • Strategic and well-versed local regulatory knowledgebase – with MOH (Pharmacy and Drug Control) Qatar
  • Team with 25+ years of strong foothold in the region
  • Proven track record for device registrations and submissions
  • End-to-end cosmetic Regulatory consultation
  • Structured and cost-effective approach to ensure speed to market